Eikos acquires stake in MysticMD

March 23, 2004 — Eikos Inc. (Profile, News, Web), a Franklin, Mass.-based developer of transparent carbon nanotube inks for conductive coatings and circuits, is acquiring a 40 percent stake in a Connecticut firm formed to develop nanotube-based medical and security devices.

Groton, Conn.-based MysticMD gains the rights to Eikos’ Invisicon nanotube formulations for products in those areas, while Eikos focuses on organic light-emitting diodes, flexible solar cells and other markets. MysticMD founder Joel Douglas said in a written statement that the partnership will allow his company to get products to market faster.

Douglas, who also serves as MysticMD’s chief technology officer, co-founded Amira Medical Inc., which developed glucose monitoring products. Roche Diagnostics acquired Amira in 2001.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.